The chicken model of spontaneous ovarian cancer

Proteomics - Clinical Applications

Volumn 8, Issue 10, 2014, Pages 689-699

  Hawkridge, Adam M ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Biomarker discovery; Chemoprevention model; Chicken; Ovarian cancer; Spontaneous tumors; Systems biology

Indexed keywords

ANIMAL; CHICKEN; DISEASE MODEL; FEMALE; HUMAN; OVARY TUMOR; PATHOPHYSIOLOGY;

ANIMALS; CHICKENS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; OVARIAN NEOPLASMS;

EID: 84949115723     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201300135     Document Type: Review

References (93)

1. Ferlay, J., Shin, H. R., Bray, F., Forman, D. et al., GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Available at http://globocan.iarc.fr2008, accessed January 2014.
2. Bast, R. C., Hennessy, B., Mills, G. B., The biology of ovarian cancer: new opportunities for translation. Nat. Rev. Cancer 2009, 9, 415-428.
3. Cho, K. R., ShihIe, M., Ovarian cancer. Annu. Rev. Pathol. 2009, 4, 287-313.
4. Yap, T. A., Carden, C. P., Kaye, S. B., Beyond chemotherapy: targeted therapies in ovarian cancer. 2009, 9, 167-181.
5. Agarwal, R., Kaye, S. B., Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat. Rev. Cancer 2003, 3, 502-516.
6. Clarke-Pearson, D. L., Clinical practice. Screening for ovarian cancer. N. Engl. J. Med. 2009, 361, 170-177.
7. Vanderhyden, B. C., Shaw, T. J., Ethier, J. F., Animal models of ovarian cancer. Reprod. Biol. Endocrinol. 2003, 1, 67.
8. Garson, K., Shaw, T. J., Clark, K. V., Yao, D. S. et al., Models of ovarian cancer-are we there yet? Mol. Cell. Endocrinol. 2005, 239, 15-26.
9. Cheon, D. J., Orsulic, S., Mouse models of cancer. Annu. Rev. Pathol. 2011, 6, 95-119.
10. Johnson, P. A., Giles, J. R., The hen as a model of ovarian cancer. Nat. Rev. Cancer 2013, 13, 432-436.
11. Benedet, J. L., Bender, H., Jones, H., 3rd, Ngan, H. Y. et al., FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int. J. Gynaecol. Obstet. 2000, 70, 209-262.
12. Scully, R. E., Sobin, L. H., Serov, S. F., Histological Typing of Ovarian Tumours. 2nd ed. Springer, Berlin; New York 1999, 136 p.
13. Auersperg, N., Wong, A. S., Choi, K. C., Kang, S. K. et al., Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr. Rev. 2001, 22, 255-288.
14. Auersperg, N., Siemens, C. H., Myrdal, S. E., Human ovarian surface epithelium in primary culture. In vitro 1984, 20, 743-755.
15. Okamura, H., Katabuchi, H., Ohba, T., What we have learned from isolated cells from human ovary? Mol. Cell. Endocrinol. 2003, 202, 37-45.
16. Shepherd, T. G., Theriault, B. L., Campbell, E. J., Nachtigal, M. W., Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients. Nat. Protoc. 2006, 1, 2643-2649.
17. Dubeau, L., Drapkin, R., Coming into focus: the nonovarian origins of ovarian cancer. Ann. Oncol. 2013, 24, viii28-viii35.
18. Karst, A. M., Levanon, K., Drapkin, R., Modeling high-grade serous ovarian carcinogenesis from the fallopian tube. Proc. Natl. Acad. Sci. USA 2011, 108, 7547-7552.
19. Kim, J., Coffey, D. M., Creighton, C. J., Yu, Z. et al., High-grade serous ovarian cancer arises from fallopian tube in a mouse model. Proc. Natl. Acad. Sci. USA 2012, 109, 3921-3926.
20. Perets, R., Wyant, G. A., Muto, K. W., Bijron, J. G. et al., Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca, Tp53, Pten models. Cancer Cell 2013, 24, 751-765.
21. McGowan, J. P., The biological significance of ovarian tumors in the fowl. J. Canc. Res. 1930, 14, 527-535.
22. Wilson, J. E., Adeno-carcinomata in hens kept in a constant environment. Poult. Sci. 1958, 37, 1253.
23. Papasolomontos, P. A., Appleby, E. C., Mayor, O. Y., Pathological findings in condemned chickens: a survey of 1, 000 carcases. Vet. Rec. 1969, 84, 459-464.
24. Fredrickson, T. N., Ovarian tumors of the hen. Environ. Health Perspect. 1987, 73, 35-51.
25. Johnson, P. A., Giles, J. R., Use of genetic strains of chickens in studies of ovarian cancer. Poult. Sci. 2006, 85, 246-250.
26. Barua, A., Bitterman, P., Abramowicz, J. S., Dirks, A. L. et al., Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. Int. J. Gynecol. Cancer 2009, 19, 531-539.
27. International Chicken Genome Sequencing Consortium, Sequence and comparative analysis of the chicken genome provide unique perspectives on vertebrate evolution. Nature 2004, 432, 695-716.
28. Bahr, J. M., The chicken as a model organism, in: Conn P. M. (Ed.), Sourcebook of Models for Biomedical Research. Human Press, Totowa 2008, pp. 161-167.
29. Barnes, M. N., Berry, W. D., Straughn, J. M., Kirby, T. O. et al., A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis. Gynecol. Oncol. 2002, 87, 57-63.
30. Urick, M. E., Giles, J. R., Johnson, P. A., VEGF expression and the effect of NSAIDs on ascites cell proliferation in the hen model of ovarian cancer. Gynecol. Oncol. 2008, 110, 418-424.
31. Urick, M. E., Giles, J. R., Johnson, P. A., Dietary aspirin decreases the stage of ovarian cancer in the hen. Gynecol. Oncol. 2009, 112, 166-170.
32. Giles, J. R., Elkin, R. G., Trevino, L. S., Urick, M. E. et al., The restricted ovulator chicken: a unique animal model for investigating the etiology of ovarian cancer. Int. J. Gynecol. Cancer 2010, 20, 738-744.
33. Carver, D. K., Barnes, H. J., Anderson, K. E., Petitte, J. N. et al., Reduction of ovarian and oviductal cancers in calorie-restricted laying chickens. Cancer Prev. Res. 2011, 4, 562-567.
34. Trevino, L. S., Buckles, E. L., Johnson, P. A., Oral contraceptives decrease the prevalence of ovarian cancer in the hen. Cancer Prev. Res. 2012, 5, 343-349.
35. Rodriguez, G. C., Barnes, H. J., Anderson, K. E., Whitaker, R. S. et al., Evidence of a chemopreventive effect of progestin unrelated to ovulation on reproductive tract cancers in the egg-laying hen. Cancer. Prev. Res. 2013, 6, 1283-1292.
36. Jackson, E., Anderson, K., Ashwell, C., Petitte, J. et al., CA125 expression in spontaneous ovarian adenocarcinomas from laying hens. Gynecol. Oncol. 2007, 104, 192-198.
37. Hakim, A. A., Barry, C. P., Barnes, H. J., Anderson, K. E. et al., Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu. Cancer Prev. Res. 2009, 2, 114-121.
38. Ansenberger, K., Zhuge, Y., Lagman, J. A., Richards, C. et al., E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer. Gynecol. Oncol. 2009, 113, 362-369.
39. Trevino, L. S., Giles, J. R., Wang, W., Urick, M. E. et al., Gene expression profiling reveals differentially expressed genes in ovarian cancer of the hen: support for oviductal origin? Horm. Cancer 2010, 1, 177-186.
40. Gonzalez Bosquet, J., Peedicayil, A., Maguire, J., Chien, J. et al., Comparison of gene expression patterns between avian and human ovarian cancers. Gynecol. Oncol. 2011, 120, 256-264.
41. Tiwari, A., Hadley, J. A., Hendricks, G. L., 3rd, Elkin, R. G. et al., Characterization of ascites-derived ovarian tumor cells from spontaneously occurring ovarian tumors of the chicken: evidence for E-cadherin upregulation. PLoS One 2013, 8, e57582.
42. Giles, J. R., Shivaprasad, H. L., Johnson, P. A., Ovarian tumor expression of an oviductal protein in the hen: a model for human serous ovarian adenocarcinoma. Gynecol. Oncol. 2004, 95, 530-533.
43. Hawkridge, A. M., Wysocky, R. B., Petitte, J. N., Anderson, K. E. et al., Measuring the intra-individual variability of the plasma proteome in the chicken model of spontaneous ovarian adenocarcinoma. Anal. Bioanal. Chem. 2010, 398, 737-749.
44. Lim, W., Jeong, W., Kim, J. H., Lee, J. Y. et al., Differential expression of alpha 2 macroglobulin in response to dietylstilbestrol and in ovarian carcinomas in chickens. Reprod. Biol. Endocrinol. 2011, 9, 137-146.
45. Skates, S. J., Xu, F. J., Yu, Y. H., Sjovall, K. et al., Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers. Cancer 1995, 76, 2004-2010.
46. Tuxen, M. K., Soletormos, G., Petersen, P. H., Schioler, V. et al., Assessment of biological variation and analytical imprecision of CA 125, CEA, and TPA in relation to monitoring of ovarian cancer. Gynecol. Oncol. 1999, 74, 12-22.
47. Tuxen, M. K., Soletormos, G., Rustin, G. J., Nelstrop, A. E. et al., Biological variation and analytical imprecision of CA 125 in patients with ovarian cancer. Scand. J. Clin. Lab. Invest. 2000, 60, 713-721.
48. Skates, S., Troiano, R., Knapp, R. C., Longitudinal CA125 detection of sporadic papillary serous carcinoma of the peritoneum. Int. J. Gynecol. Cancer 2003, 13, 693-696.
49. Skates, S. J., Menon, U., MacDonald, N., Rosenthal, A. N. et al., Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women. J. Clin. Oncol. 2003, 21, 206s-210s.
50. Dixon, R. B., Bereman, M. S., Petitte, J. N., Hawkridge, A. M. et al., One-year plasma N-linked glycome intra-individual and inter-individual variability in the chicken model of spontaneous ovarian adenocarcinoma. Int. J. Mass Spectrom. 2011, 305, 79-86.
51. Andrews Kingon, G. L., Petitte, J. N., Muddiman, D. C., Hawkridge, A. M., Multi-peptide nLC-PC-IDMS-SRM-based assay for the quantification of biomarkers in the chicken ovarian cancer model. Methods 2013, 61, 323-330.
52. Fathalla, M. F., Incessant ovulation-a factor in ovarian neoplasia? Lancet 1971, 2, 163.
53. Wu, M. L., Whittemore, A. S., Paffenbarger, R. S., Jr., Sarles, D. L. et al., Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use. Am. J. Epidemiol. 1988, 128, 1216-1227.
54. Naora, H., Montell, D. J., Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat. Rev. Cancer 2005, 5, 355-366.
55. Silverthorn, D. U., Ober, W. C., Garrison, C. W., Silverthorn, A. C., Human Physiology: An Integrated Approach. 2nd ed. Prentice Hall, Upper Saddle River, NJ 2001, 815 p.
56. Whittow, G. C. (Ed.), Sturkie's Avian Physiology. 5th ed. Academic Press, San Diego, CA 2000.
57. Auersperg, N., Specific keynote: experimental models of epithelial ovarian carcinogenesis. Gynecol. Oncol. 2003, 88, S47-S51.
58. Ocon-Grove, O. M., Maddineni, S., Hendricks, G. L., 3rd, Elkin, R. G. et al., Pituitary progesterone receptor expression and plasma gonadotrophin concentrations in the reproductively dysfunctional mutant restricted ovulator chicken. Domest. Anim. Endocrinol. 2007, 32, 201-215.
59. Riman, T., Persson, I., Nilsson, S., Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin. Endocrinol. 1998, 49, 695-707.
60. Coussens, L. M., Werb, Z., Inflammation and cancer. Nature 2002, 420, 860-867.
61. Eilati, E., Pan, L., Bahr, J. M., Hales, D. B., Age dependent increase in prostaglandin pathway coincides with onset of ovarian cancer in laying hens. Prostaglandins Leukot. Essent. Fatty Acids 2012, 87, 177-184.
62. Barua, A., Abramowicz, J. S., Bahr, J. M., Bitterman, P. et al., Detection of ovarian tumors in chicken by sonography: a step toward early diagnosis in humans? J. Ultrasound Med. 2007, 26, 909-919.
63. Bast, R. C., Feeney, M., Lazarus, H., Nadler, L. M. et al., Reactivity of a monoclonal-antibody with human ovarian-carcinoma. J. Clin. Invest. 1981, 68, 1331-1337.
64. Bast, R. C., Klug, T. L., Stjohn, E., Jenison, E. et al., A Radioimmunoassay using a monoclonal-antibody to monitor the course of epithelial ovarian-cancer. N. Engl. J. Med 1983, 309, 883-887.
65. Rodriguez-Burford, C., Barnes, M. N., Berry, W., Partridge, E. E. et al., Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. Gynecol. Oncol. 2001, 81, 373-379.
66. Cancer Genome Atlas Research Network, Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474, 609-615.
67. Ahmed, A. A., Etemadmoghadam, D., Temple, J., Lynch, A. G. et al., Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J. Pathol. 2010, 221, 49-56.
68. Liu, J., Yang, G., Thompson-Lanza, J. A., Glassman, A. et al., A genetically defined model for human ovarian cancer. Canc. Res. 2004, 64, 1655-1663.
69. Nakayama, N., Nakayama, K., Yeasmin, S., Ishibashi, M. et al., KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer. Br. J. Cancer. 2008, 99, 2020-2028.
70. Tuefferd, M., Couturier, J., Penault-Llorca, F., Vincent-Salomon, A. et al., HER2 status in ovarian carcinomas: a multicenter GINECO study of 320 patients. PLoS One 2007, 2, e1138.
71. Geiger, B., Ayalon, O., Cadherins. Annu. Rev. Cell Biol. 1992, 8, 307-332.
72. Lim, C. H., Lim, W., Jeong, W., Lee, J. Y. et al., Avian WNT4 in the female reproductive tracts: potential role of oviduct development and ovarian carcinogenesis. PLoS One 2013, 8, e65935.
73. Orelli, B. J., Logsdon, J. M., Jr., Bishop, D. K., Jr., Nine novel conserved motifs in BRCA1 identified by the chicken orthologue. Oncogene 2001, 20, 4433-4438.
74. Takata, M., Tachiiri, S., Fujimori, A., Thompson, L. H. et al., Conserved domains in the chicken homologue of BRCA2. Oncogene 2002, 21, 1130-1134.
75. Giles, J. R., Olson, L. M., Johnson, P. A., Characterization of ovarian surface epithelial cells from the hen: a unique model for ovarian cancer. Exp. Biol. Med. 2006, 231, 1718-1725.
76. Urick, M. E., Johnson, P. A., Cyclooxygenase 1 and 2 mRNA and protein expression in the Gallus domesticus model of ovarian cancer. Gynecol. Oncol. 2006, 103, 673-678.
77. Stammer, K., Edassery, S. L., Barua, A., Bitterman, P. et al., Selenium-binding protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer. Gynecol. Oncol. 2008, 109, 115-121.
78. Zhuge, Y., Lagman, J. A., Ansenberger, K., Mahon, C. J. et al., CYP1B1 expression in ovarian cancer in the laying hen Gallus domesticus. Gynecol. Oncol. 2009, 112, 171-178.
79. Ahn, S. E., Choi, J. W., Rengaraj, D., Seo, H. W. et al., Increased expression of cysteine cathepsins in ovarian tissue from chickens with ovarian cancer. Reprod. Biol. Endocrinol. 2010, 8, 100.
80. Seo, H. W., Rengaraj, D., Choi, J. W., Ahn, S. E. et al., Claudin 10 is a glandular epithelial marker in the chicken model as human epithelial ovarian cancer. Int. J. Gynecol. Cancer 2010, 20, 1465-1473.
81. Choi, J. W., Ahn, S. E., Rengaraj, D., Seo, H. W. et al., Matrix metalloproteinase 3 is a stromal marker for chicken ovarian cancer. Oncol. Lett. 2011, 2, 1047-1051.
82. Seo, H. W., Rengaraj, D., Choi, J. W., Park, K. J. et al., The expression profile of apoptosis-related genes in the chicken as a human epithelial ovarian cancer model. Oncol. Rep. 2011, 25, 49-56.
83. Yu, Y., Edassery, S. L., Barua, A., Abramowicz, J. S. et al., The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors. J. Ovarian Res. 2011, 4, 12.
84. Jeong, W., Kim, H. S., Kim, Y. B., Kim, M. A. et al., Paradoxical expression of AHCYL1 affecting ovarian carcinogenesis between chickens and women. Exp. Biol. Med. 2012, 237, 758-767.
85. Lee, J. Y., Jeong, W., Kim, J. H., Kim, J. et al., Distinct expression pattern and post-transcriptional regulation of cell cycle genes in the glandular epithelia of avian ovarian carcinomas. PLoS One 2012, 7, e51592.
86. Lee, J. Y., Jeong, W., Lim, W., Kim, J. et al., Chicken pleiotrophin: regulation of tissue specific expression by estrogen in the oviduct and distinct expression pattern in the ovarian carcinomas. PLoS One 2012, 7, e34215.
87. Lim, W., Jeong, W., Kim, J., Ka, H. et al., Differential expression of secreted phosphoprotein 1 in response to estradiol-17beta and in ovarian tumors in chickens. Biochem. Biophys. Res. Commun. 2012, 422, 494-500.
88. Lim, W., Kim, H. S., Jeong, W., Ahn, S. E. et al., SERPINB3 in the chicken model of ovarian cancer: a prognostic factor for platinum resistance and survival in patients with epithelial ovarian cancer. PLoS One 2012, 7, e49869.
89. Lim, W., Kim, J. H., Ahn, S. E., Jeong, W. et al., Avian SERPINB11 gene: a marker for ovarian endometrioid cancer in chickens. Exp. Biol. Med. 2012, 237, 150-159.
90. Bae, S. M., Lim, W., Jeong, W., Lee, J. Y. et al., Hormonal regulation of beta-catenin during development of the avian oviduct and its expression in epithelial cell-derived ovarian carcinogenesis. Mol. Cell. Endocrinol. 2013, 382, 46-54.
91. Bradaric, M. J., Penumatsa, K., Barua, A., Edassery, S. L. et al., Immune cells in the normal ovary and spontaneous ovarian tumors in the laying hen (Gallus domesticus) model of human ovarian cancer. PLoS One 2013, 8, e74147.
92. Lee, J. Y., Jeong, W., Lim, W., Lim, C. H. et al., Hypermethylation and post-transcriptional regulation of DNA methyltransferases in the ovarian carcinomas of the laying hen. PLoS One 2013, 8, e61658.
93. Lim, W., Jeong, W., Kim, J., Yoshimura, Y. et al., Expression and regulation of beta-defensin 11 in the oviduct in response to estrogen and in ovarian tumors of chickens. Mol. Cell. Endocrinol. 2013, 366, 1-8.